Chapt 10 Stucy Guide: Complications of Pregnancy Practice Flashcards

High-Risk Pregnancy and Prenatal Care

  • Definition of High-Risk Pregnancy: A pregnancy in which the mother, the baby, or both parties are at an increased risk for complications, illness, injury, or death.

  • Causes of High-Risk Status:

    • Acquired during pregnancy: Conditions that develop specifically due to the gestational state, such as gestational hypertension or preeclampsia.

    • Pre-existing conditions: Factors present before conception, including diabetes, chronic hypertension, and obesity.

  • Importance of Prenatal Care:

    • Allows for the early identification of pre-existing medical conditions.

    • Facilitates early intervention, which significantly improves outcomes for the mother and the fetus.

    • Key components include regular prenatal visits, screening tests, and comprehensive patient education.

  • The Nurse's Role:

    • Identifying risk factors and recognizing early warning signs.

    • Monitoring both maternal and fetal status throughout the pregnancy.

    • Providing essential education and emotional support to the patient.

Hemorrhagic Conditions of Early Pregnancy: Spontaneous Abortion

  • Definition of Spontaneous Abortion (Miscarriage): The loss of a pregnancy occurring before 2020 weeks of gestation.

  • Post-2020 Weeks Classification: Loss after this threshold is classified as a stillbirth or fetal demise.

  • Causes of Miscarriage:

    • Chromosomal Abnormalities: Account for approximately 50%50\% of first-trimester miscarriages. These are usually random genetic errors and are not the fault of the mother.

    • Faulty Implantation: Inadequate blood supply to the placenta.

    • Maternal Infections: Viral, bacterial, or parasitic infections that interfere with proper fetal development.

    • Maternal Medical Conditions: Examples include uncontrolled diabetes, thyroid disorders, autoimmune diseases, and severe hypertension.

    • Placental Abnormalities: Improper development or functioning of the placenta.

    • Clotting Disorders: Conditions like Antiphospholipid syndrome, which causes small clots in placental vessels.

  • Emotional Impact: The loss triggers a grief response related to the loss of hopes, dreams, and future plans. Nurses must provide compassionate care and acknowledge the loss's significance.

  • Types of Miscarriage:

    • Threatened Miscarriage: Characterized by vaginal bleeding before 2020 weeks. The cervix remains closed, and the pregnancy may continue with close monitoring.

    • Inevitable Miscarriage: The loss cannot be prevented. Bleeding is present, the cervix has begun to dilate, and membranes may have ruptured as the body begins expelling the pregnancy.

    • Incomplete Miscarriage: Some, but not all, products of conception are expelled. Retained tissue prevents the uterus from contracting, leading to continued bleeding and risk of hemorrhage. Treatment includes Dilatation and Curettage (D&CD\&C) or medications such as oxytocin, methergine, or cyotec.

    • Complete Miscarriage: All products of conception are expelled. The uterus is empty, the cervix closes, and symptoms like bleeding and cramping decrease.

    • Missed Miscarriage: The fetus has died in utero but has not been expelled. Symptoms of pregnancy diminish, and ultrasound reveals no fetal cardiac activity. Management options include expectant management, medication-induced evacuation, or surgical intervention.

    • Recurrent (Habitual) Miscarriage: Defined as 33 or more consecutive pregnancy losses. This requires evaluation for genetic, uterine, hormonal, autoimmune, or clotting disorders.

  • Assessment and Treatment:

    • Assess vaginal bleeding (amount, color, duration, presence of clots) and associated symptoms (cramping, abdominal/back pain).

    • Instruct the patient to save any passed tissue.

    • Interventions include IVIV fluids, blood products, medications, and surgical procedures.

    • Rh-Negative Mothers: Must receive RhoGAMRhoGAM to prevent sensitization.

Ectopic Pregnancy

  • Definition: A condition where the fertilized ovum implants outside the uterine cavity.

  • Common Sites:

    • Fallopian Tubes: The most common site, accounting for 90-95%90\text{-}95\% of cases.

    • Other Sites: Ovary, cervix, abdominal cavity, or a previous C-section scar.

  • The Danger: Growing tissue can rupture the fallopian tube, leading to life-threatening internal hemorrhage.

  • Risk Factors: History of pelvic inflammatory disease (PIDPID), previous ectopic pregnancy, tubal surgery, infertility treatments, endometriosis, smoking, or any condition causing tubal scarring.

  • Viability: Ectopic pregnancies are never viable; treatment is always necessary.

  • Classic Presentation:

    • Unilateral pelvic or abdominal pain.

    • Referred shoulder (scapular) pain.

    • Vaginal spotting.

    • Missed period followed by bleeding.

    • Dizziness, weakness, and initial positive pregnancy test/symptoms.

  • Ruptured Ectopic Pregnancy: An obstetrical emergency characterized by severe abdominal pain, rigidity, and hypotension. External bleeding does not necessarily reflect the extent of internal blood loss.

  • Diagnosis: Lab studies showing quantitative hCGhCG levels rising slower than normal and transvaginal ultrasound to locate the gestational sac.

  • Management:

    • Medication (Methotrexate): A folic acid antagonist used in stable, early cases to stop cell growth and allow reabsorption. Requires serial hCGhCG follow-ups.

    • Surgical Intervention: Necessary if the pregnancy is ruptured or the patient is unstable; involves removing the ectopic growth and potentially the fallopian tube.

  • Education: Patients on Methotrexate must report severe pain, heavy bleeding, or dizziness immediately.

Gestational Trophoblastic Disease (Molar Pregnancy)

  • Definition: Abnormal proliferation of trophoblastic cells that form fluid-filled, grape-like vesicles.

  • Types:

    • Complete Mole: Entirely abnormal placental tissue with no fetal tissue present.

    • Partial Mole: May contain some fetal tissue, but chromosomal abnormalities make the fetus non-viable.

    • Complication: Risk of developing choriocarcinoma, a highly treatable cancer.

  • Clinical Presentation:

    • Vaginal bleeding in the first trimester.

    • Uterus larger than expected for gestational age.

    • Extremely elevated hCGhCG levels.

    • Severe nausea and vomiting.

    • Passage of grape-like vesicles (hallmarkhallmark finding).

  • Diagnosis and Treatment:

    • Ultrasound showing a "snowstorm appearance."

    • Treatment involves suction curettage or D&CD\&C. Hysterectomy may be necessary for excessive bleeding.

    • Follow-up: Serial hCGhCG monitoring for months. Patients must avoid pregnancy for at least 11 year to ensure hCGhCG readings are not masked by a new pregnancy and to monitor for malignancy.

Hemorrhagic Conditions of Late Pregnancy: Placenta Previa

  • Definition: The placenta implants in the lower uterine segment, over or near the cervical opening.

  • Mechanism: Uterine stretching disrupts placental attachment, causing bleeding.

  • Types:

    • Low-lying: Near the cervical opening.

    • Marginal: At the edge of the opening.

    • Partial: Covers part of the opening.

    • Complete: Completely covers the cervical opening.

  • Placental Migration: Many low-lying placentas appear to "move" upward as the uterus grows. This is a change in relative position, not physical migration, and may resolve by the third trimester.

  • Risk Factors: Previous C-section (strongest factor), previous previa, multiple gestation, advanced maternal age, smoking, multiparity, and IVFIVF.

  • Classic Presentation: Sudden, painless, bright red vaginal bleeding after 2020 weeks. Uterus is typically soft and non-tender.

  • Risks:

    • Maternal: Recurrent hemorrhage, anemia, shock, C-section, and prolonged hospitalization.

    • Fetal: Preterm birth, growth restriction, and hypoxia.

  • Nursing Care and Safety:

    • Monitor bleeding, vital signs, and fetal heart rate.

    • Establish IVIV access and obtain labs (H&HH\&H, type, and crossmatch).

    • Safety Restriction: AVOID DIGITAL VAGINAL EXAMS until previa is ruled out by ultrasound; digital exams can cause catastrophic hemorrhage.

    • Teach pelvic rest (no sexual intercourse), activity restrictions, and the need to report bleeding immediately.

Abruptio Placentae (Placental Abruption)

  • Definition: Premature separation of a normally implanted placenta from the uterine wall after 2020 weeks and before delivery.

  • Risk Factors: Maternal hypertension, preeclampsia, abdominal trauma, smoking, substance abuse (cocaine/heroin), and previous abruption.

  • Types of Abruption:

    • Partial Abruption (Apparent): Blood escapes through the cervix; visible bleeding is present.

    • Partial Concealed Abruption: Blood is trapped behind the placenta; little to no visible bleeding.

    • Complete Concealed Abruption: The entire placenta separates, but blood is trapped. This is the most severe form, leading to fetal distress or demise and maternal shock.

    • Complete Apparent Abruption: Entire separation with massive vaginal hemorrhage.

  • Signs/Symptoms: Sudden vaginal bleeding, severe abdominal pain, a "board-like" rigid uterus, uterine irritability, and fetal distress (e.g., late decelerations, decreased variability).

  • Consequences:

    • Maternal: Disseminated intravascular coagulation (DICDIC), renal failure, shock.

    • Fetal: Hypoxic-ischemic encephalopathy, preterm birth, or death.

Hyperemesis Gravidarum

  • Definition: A severe form of nausea and vomiting that interferes with nutrition and hydration.

  • Etiology: Likely linked to high levels of hCGhCG and estrogen. Higher risk in multiple gestation or molar pregnancies.

  • Distinction from Morning Sickness: Results in significant weight loss, dehydration, ketonuria, and electrolyte imbalances.

  • Treatment Goals: Restore hydration via IVIV fluids, correct electrolyte disturbances (especially potassium), improve nutrition via a gradual diet introduction (clear liquids to bland foods), and manage with anti-emetics (Ondansetron/Zofran, Vitamin B6B6).

Hypertensive Disorders of Pregnancy

  • Gestational Hypertension: Hypertension (140/90mmHg≥ 140/90\,mmHg) developing after 2020 weeks without proteinuria or organ dysfunction. Blood pressure usually returns to normal postpartum.

  • Preeclampsia:

    • Definition: A pregnancy-specific syndrome starting after 2020 weeks involving hypertension and organ involvement.

    • Diagnostic Criteria: BP140/90mmHgBP ≥ 140/90\,mmHg on two occasions 44 hours apart, plus organ involvement indicators:

      • Proteinuria: 300mg≥ 300\,mg in 2424 hours or 2+≥ 2+ on dipstick.

      • Thrombocytopenia: Platelets < 100,000/μ L.

      • Renal Insufficiency: Serum creatinine > 1.1\,mg/dL or doubling of baseline.

      • Impaired Liver Function: Elevated AST/ALTAST/ALT.

      • Other: Pulmonary edema, or new-onset cerebral/visual disturbances.

    • Symptoms: Headaches, blurred vision, flashing lights, edema in face/hands, and epigastric or right upper quadrant pain.

  • Classification:

    • Mild Preeclampsia: BP140/90mmHgBP ≥ 140/90\,mmHg, proteinuria 1+≥ 1+, minimal lab changes.

    • Severe Preeclampsia: BP160/110mmHgBP ≥ 160/110\,mmHg (twice, 66 hours apart), proteinuria 300mg≥ 300\,mg or 3+≥ 3+ dipstick, severe headaches, hyperreflexia, clonus, and decreased urine output.

Management of Preeclampsia and Eclampsia

  • Magnesium Sulfate Therapy:

    • Purpose: Used as an anticonvulsant to prevent seizures, not for blood pressure control.

    • Dosing: Loading dose of 4-6gIV4\text{-}6\,g\,IV, followed by a maintenance infusion of 1-2g/hr1\text{-}2\,g/hr.

    • Therapeutic Range: 4-8mg/dL4\text{-}8\,mg/dL.

    • Monitoring: Hourly checks on neuro status, respiratory rate, DTRsDTRs, clonus, and urine output (Mg is excreted by the kidneys).

    • Toxicity Signs: Decreased DTRsDTRs (early), muscle weakness, respiratory depression, and hypotension.

    • Antidote: Calcium gluconate (must be at the bedside).

  • Eclampsia: Progression to grand mal seizures. Treatment focuses on stopping the seizure (MagnesiumSulfateMagnesium Sulfate bolus), stabilizing the patient, and managing the fetus.

HELLP Syndrome and Chronic Hypertension

  • HELLP Syndrome Acronym:

    • H: Hemolysis (RBC breakdown).

    • EL: Elevated Liver enzymes (obstructed flow causing pain/enlargement).

    • LP: Low Platelets (consumption at damage sites).

  • HELLP Treatment: Delivery is the only definitive treatment.

  • Chronic Hypertension: Hypertension present before pregnancy or before 2020 weeks. Monitor for "superimposed preeclampsia" and fetal growth restriction.

Blood Incompatibility: Rh and ABO Systems

  • Rh Incompatibility: Occurs when an Rh-negative mother carries an Rh-positive fetus.

    • Problem: Hemolysis of fetal red blood cells, leading to anemia, hyperbilirubinemia, and hydrops fetalis (generalized edema/heart failure).

    • Prevention: Administer RhoGAMRhoGAM at 28-3228\text{-}32 weeks and within 7272 hours postpartum (if the infant is Rh-positive).

    • Testing: Indirect Coombs (maternal blood for antibodies) and Direct Coombs (cord blood for antibodies on fetal cells).

  • ABO Incompatibility: Occurs when the mother is Type OO and the fetus is Type AA, BB, or ABAB.

    • Mechanism: Naturally occurring anti-AA and anti-BB antibodies in the mother cross the placenta.

    • Severity: Usually mild; results in newborn jaundice and mild anemia.

Diabetes Mellitus in Pregnancy

  • Gestational Diabetes (GDM): First recognized during pregnancy; placental hormones (estrogen, progesterone, human placental lactogen) act as insulin antagonists, increasing resistance.

  • Maternal/Fetal Complications: Higher risk of spontaneous abortion, UTIsUTIs, polyhydramnios (from fetal polyuria), congenital malformations (neural tube, cardiac), and macrosomia.

  • Neonatal Hypoglycemia: At birth, high fetal insulin levels persist without the maternal glucose supply, risking neurologic damage.

  • Respiratory Distress Syndrome (RDS): Excess insulin delays surfactant production.

  • Screening Procedures:

    • 1-hour Glucose Challenge: 24-2824\text{-}28 weeks. Non-fasting. Positive if > 140\,mg/dL.

    • 3-hour Oral Glucose Tolerance Test (OGTT): Diagnostic test. Fasting required.

    • Normal OGTT Thresholds: Fasting < 95, 1-hr < 180, 2-hr < 155, 3-hr < 140\,mg/dL. (Diagnosis requires 22 or more abnormal values).

  • Management: Dietary modification (primary), insulin (preferred medication as it doesn't cross the placenta), and regular fetal surveillance (NSTNST, BPPBPP, ultrasound).

Obesity in Pregnancy

  • Risks: Decreased fertility preconception; increased risk of GDMGDM, preeclampsia, and C-section during pregnancy.

  • Weight Gain Recommendation: 11-2011\text{-}20 pounds for women entering pregnancy with obesity.

  • Clinical Challenges: Need for specialized equipment (largeBPcuffslarge\,BP\,cuffs, bariatric beds) and difficulty with external monitoring.

  • Postpartum Risks: Venous thromboembolism (VTEVTE), poor wound healing, and infection.

TORCH Infections and Other Maternal Infections

  • TORCH Overview: Acronym for group of infections causing miscarriage, stillbirth, or severe birth defects.

    • T (Toxoplasmosis): Parasite from undercooked meat or cat feces. Causes vision/neuro problems. Treatment: Spiramycin.

    • O (Other): Syphilis, HIVHIV, Varicella.

    • R (Rubella): Risk of Congenital Rubella Syndrome (hearing loss, cataracts, heart defects). MMR vaccine is a live vaccine and must be given before pregnancy.

    • C (Cytomegalovirus/CMV): Most common congenital viral infection. Often asymptomatic in mothers. Causes microcephaly and developmental delays.

    • H (Herpes Simplex/HSV): Concern is neonatal transmission during labor. C-section required if active lesions present. Antivirals (ValacyclovirValacyclovir) given starting at 3636 weeks for suppression.

  • Group Beta Streptococcus (GBS):

    • Diagnosis: Vaginal/rectal culture at 34-3634\text{-}36 weeks.

    • Treatment: IVIV antibiotics (Penicillin) during labor. Goal is 22 doses, 44 hours apart, prior to delivery.

  • HIV Management: Routine screening; treatment with Antiretroviral Therapy (ARTART) to reduce viral load. C-section recommended if viral load is high. Breastfeeding is avoided in the USUS to prevent transmission.

  • COVID-19: Breastfeeding is supported as the benefits and maternal antibody protection outweigh risks.